telephone number icon 844.997.3231

Labor Day Sale! Up to 50% OFF! Hurry—Sale Ends Fri, Sep 18 Save Now >>

Get Up to 50% OFF Sitewide—Labor Day SaleGet Up to 50% OFF Sitewide

OFFER ENDS Fri, Sep 18

00

Days
:

00

Hrs
:

00

Mins
:

00

Secs
Claim Offer

Vascular occlusion asymmetry is the most under-used diagnostic sign in aesthetic medicine, and it is available for free on every complication you will ever assess. The question is not what colour the tissue is. The question is: where does the abnormality stop, and does that boundary have a reason?

Injectors are trained to interrogate the appearance of tissue — is it blanched, is it mottled, is it dusky. Appearance is genuinely ambiguous, and a great deal of ink has been spent on how ambiguous it is. Distribution is much less ambiguous, because distribution is generated by anatomy, and anatomy is not ambiguous at all. A perfusion deficit has to obey the arterial tree. Trauma, oedema and immune reactions do not.

That difference is the whole tell, and in the lips it is unusually clean.

The case, as a distribution problem

Michelle Langston's teaching case is a healthy adult treated for upper lip definition with hyaluronic acid placed in small aliquots. Within roughly fifteen minutes of leaving she calls the office. The upper lip shows blanching, then mottling, then change spreading across the whole upper lip. The lower lip is normal.

Langston's reasoning, stated on camera, is a single sentence of distribution logic: what tells me this is also ischemia — there's no bottom lip involvement, because I didn't inject in that area in that same injection pattern.

Unpack what that sentence is actually doing. She is not reading the involved tissue. She is reading the uninvolved tissue, and using it as an internal control. The lower lip received no needle, no volume, no product and no manipulation — and it is clean. The upper lip received all four, and it is abnormal. The abnormality therefore maps onto the treated region.

Now ask which mechanisms can produce that map.

Why sparing is the informative half

Three broad categories of thing go wrong after filler, and they have different geometries.

Generalised or diffuse processes — a delayed hypersensitivity reaction, a biofilm or infectious process, an inflammatory response to product, generalised post-procedure oedema — do not respect arterial boundaries. They involve product wherever product is, they tend to be bilateral when treatment was bilateral, and their edges are soft and gradual. Crucially, when they do produce asymmetry it is because the product was distributed asymmetrically, not because a supply territory was.

Mechanical trauma — needle tracks, ecchymosis, oedema from the volume itself — is a puncture-and-plane phenomenon. It is multifocal, it corresponds to entry points, and over hours it migrates with gravity and along fascial planes rather than along vessels. It is also generously distributed: if you made ten passes across the upper lip, you traumatised the upper lip broadly and in a scattered pattern.

A perfusion deficit is the only one of the three whose shape is dictated by a branching arterial network. It occupies a contiguous segment of tissue supplied by the obstructed vessel and its distal bed. Its boundary is where another vessel's supply takes over. It is very often unilateral even when treatment was bilateral, because a single vessel was entered.

So the reasoning is not "the upper lip is abnormal, therefore ischemia." It is: an equally traumatised, equally exposed, immediately adjacent region is normal, and the abnormality respects a boundary that trauma and inflammation have no reason to respect. That argues away from generalised processes and toward a supply problem in a specific territory.

Sparing is the informative half of the finding. Most injectors photograph and describe only the abnormal tissue, and in doing so they discard the half of the exam that carries the discriminating information.

The anatomic basis: territories, not points

The reason distribution behaves this reliably is that facial skin is not perfused diffusely. It is perfused in compartments.

The angiosome concept — a block of tissue supplied by a named source artery, linked to its neighbours by anastomoses — was mapped for the head and neck by Houseman, Taylor and Pan (Plast Reconstr Surg 2000;105:2287-2313). Within each angiosome, individual cutaneous perforators supply smaller perforasomes, interconnected by direct subcutaneous anastomoses and indirect sub-dermal choke vessels. In the face, this cutaneous compartmentalisation approximates the superficial fat compartments described by Rohrich and Pessa (Plast Reconstr Surg 2007;119:2219-2227), which is the anatomic reason clinical injury patterns recur in recognisable shapes rather than appearing randomly (Soares, Molecules 2022;27:5398).

The empirical confirmation is the largest photographic series available. Soares and colleagues reviewed 243 published photographic cases of filler-induced facial skin ischemia and scored them by angiosome, introducing the FOEM (facial, ophthalmic, distal external carotid, internal maxillary) system. The facial artery angiosome was involved in 58% of cases and the ophthalmic in 48%, and the injuries occupied identifiable facial skin segments rather than arbitrary areas (Plast Reconstr Surg 2023;151:592e-608e). The distribution of these injuries is described in that work as non-random but variable — which is exactly the right phrase to carry into the treatment room. Patterns recur. They are not identical between patients.

For the lips, the practical consequence is that the upper and lower vermilion are supplied by different named branches. A lower lip that is normal while the upper lip deteriorates is not a coincidence of appearance; it is two supply territories behaving independently, which is what supply territories do. Empire covers this perioral arterial arrangement in Anatomical Based Aesthetics Training and, in tissue, in Special Anatomical Cadaver Aesthetics Training.

The three asymmetries worth naming

In practice the tell shows up in three forms, and they are worth having as named objects so you can look for them deliberately.

Unilateral involvement after bilateral treatment. You injected both sides. One side is abnormal. Whatever you did, you did to both, so a mechanism that acts on product or on tissue generally should have produced a bilateral result. A mechanism that acts on one vessel produced this one. This is the strongest form of the tell and it is the one most often dismissed because "I probably just bruised that side."

Regional involvement with a directly adjacent spared region. Langston's case. The comparison tissue is millimetres away, received the same environment, the same ice, the same anaesthetic, the same patient, the same lighting — and differs. There is almost no confounding left.

Involvement that extends beyond the treated field but still stops somewhere sensible. This is the form that confuses people, because it looks like it contradicts the first two. Findings frequently appear in tissue you never touched, downstream of the obstruction. That is expected — the territory is bigger than the deposit. The tell still holds, because the involved area remains bounded, and the boundary is a vascular one. Ask not "is this where I injected" but "could one vessel explain everything I am seeing and nothing I am not."

Where the tell fails

Evidence honesty matters more here than anywhere, because a sign this useful invites over-reading. The asymmetry tell raises or lowers probability. It never proves anything, and there are four situations where it misleads.

Bilateral occlusion is possible. If you performed the same manoeuvre at the same depth with the same technique on both sides, you can enter a vessel on both sides. Symmetry does not exclude occlusion; it only removes one line of evidence.

Anastomoses cross the midline. The perioral arterial supply is richly interconnected, and flow can reach an area from more than one direction. Involvement can therefore cross boundaries that a simple territory diagram would predict it should respect. The literature describes the pattern as non-random but variable, and that second half is load-bearing.

Product distribution can make a diffuse process look focal. If you placed markedly more product in one region, a delayed inflammatory reaction or a nodule may present asymmetrically for reasons that have nothing to do with perfusion. Check whether the asymmetry of the finding matches the asymmetry of the product, and whether the timeline fits an inflammatory process rather than an acute one.

Compression can produce a territorial pattern without anything being intravascular. Enough volume in a tight space can reduce perfusion in a territory. That distinction changes the mechanism discussion, but at the bedside it changes very little: the tissue is still under-perfused, and the assessment and the threshold to act are unchanged.

None of these is a reason to ignore the sign. They are reasons to use it as one strong input into a decision that stays weighted toward acting.

Making it a procedure instead of an intuition

A sign you notice when you happen to notice it is not a sign you own. Three habits convert it.

Declare the control tissue before you inject. At the point you plan the treatment, decide what you will compare against — the lower lip, the contralateral side, the untreated cutaneous lip — and say it. If you are treating bilaterally and have no natural control, your control is the contralateral side and you should expect symmetry; asymmetry then becomes the finding.

Assess in a fixed order, involved and uninvolved. Colour, capillary refill, temperature, patient-reported pain: perform all four on the involved region and then all four on the control region, in that order, every time. Injectors reliably examine the abnormal side and forget to examine the normal one, which is the single change that makes the tell work.

Photograph and describe the unit, not the lesion. Capture the whole perioral unit straight on, at a distance where both lips and both sides are in frame, so the spared tissue is in the record. An image cropped to the abnormality has thrown away the diagnosis. Then describe the boundary in words — where it starts, where it stops, and what it corresponds to.

Langston's summary of the habit is characteristically plain: make sure you're looking at the lip and treating it as a whole — you can use the bottom lip, we don't have to just look at the top lip and say, oh, this is perfect.

These figures and techniques reflect Michelle Langston's clinical practice as taught in Empire Medical Training's hands-on curriculum. Technique is learned under supervision; this article is educational and is not a substitute for training.

What the tell changes about the decision

Nothing about the asymmetry tell changes the threshold to act. Langston's rule stands: if there is any question, you treat, you stop injecting, and you run the protocol you have already rehearsed. Distribution reasoning is not a way to talk yourself out of treating.

What it changes is the speed and the confidence with which you get there. An injector who has trained themselves to look at the spared tissue arrives at "this is vascular" in seconds, with something concrete to say to the patient and to whoever they escalate to. An injector who only looks at the abnormal tissue is left arguing about the colour of a lip, which is an argument nobody wins in time.

For the mechanics of hyaluronidase once that decision is made, see dissolving filler; for the patient-facing account of what ordinary post-treatment lip change looks like, common lip filler reactions and how to avoid them is the piece to send. Perioral technique with complication recognition built into the hands-on work is covered in Empire's Complete Dermal Filler Training.

Part of Vascular Occlusion: Recognition and Response.

Train with Empire

This guide is clinical education. The technique behind it is taught hands-on, on live patients, with faculty beside you.

Explore Complete Dermal Filler Training →

Disclaimer

This article reflects the clinical opinions and experience of Michelle Langston, APRN, MSN, FNP-BC, an independent faculty member contributing to Empire Medical Training's curriculum. The views expressed are the author's own and do not necessarily represent those of Empire Medical Training.

It is professional education, not medical advice, and is no substitute for hands-on training or independent clinical judgment. Licensed clinicians remain responsible for their own patient selection, technique and outcomes, for verifying current product labelling, and for practising within their scope and applicable law. Empire Medical Training accepts no liability for reliance on this content.

Frequently Asked Questions

Does symmetric involvement rule out vascular occlusion?

No. Bilateral treatment performed with the same technique at the same depth can produce bilateral vascular events, and richly anastomotic perioral supply can distribute findings in ways a simple territory map would not predict. Symmetry removes one line of supporting evidence; it does not remove the diagnosis or lower the threshold to assess perfusion directly.

Why does the finding sometimes appear where I did not inject?

Because the affected territory is larger than the deposit. Product that enters a vessel affects everything downstream of the obstruction, so skin change commonly appears centimetres from the puncture. The distribution tell still applies — the involved area should remain bounded in a way that one vessel's supply could explain.

How is this different from just noticing that one side looks worse?

Noticing is passive and inconsistent. The tell is a deliberate comparison: you name a control region before treating, examine it with the same four items in the same order, and document where the abnormality stops. The information lives in the spared tissue, which is precisely the tissue injectors skip when they are worried.

Can a delayed hypersensitivity reaction present asymmetrically?

Yes, particularly when product volume was markedly asymmetric. The discriminators are timeline and the perfusion findings themselves — inflammatory processes generally evolve over days with preserved capillary refill and normal temperature, whereas an acute perfusion deficit shows sluggish refill, coolness and progression measured in minutes to hours.

Should distribution ever make me decide not to treat?

No. Distribution reasoning is for reaching the diagnosis faster and communicating it more clearly, not for standing down. The asymmetry of the harms is unchanged: dissolving product you did not need to dissolve is recoverable, and a missed perfusion deficit is not. Any genuine question still resolves toward treating.